IRIS
GABRIELLI, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.801
EU - Europa 10.235
AS - Asia 7.018
SA - Sud America 1.974
AF - Africa 395
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 9
AN - Antartide 1
Totale 35.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.515
RU - Federazione Russa 2.686
SG - Singapore 2.167
VN - Vietnam 1.623
BR - Brasile 1.529
IT - Italia 1.399
UA - Ucraina 1.376
CN - Cina 1.149
DE - Germania 955
SE - Svezia 919
IE - Irlanda 747
FR - Francia 566
TR - Turchia 513
HK - Hong Kong 512
DK - Danimarca 464
FI - Finlandia 426
GB - Regno Unito 318
KR - Corea 249
IN - India 164
BD - Bangladesh 158
AR - Argentina 146
CA - Canada 130
CI - Costa d'Avorio 130
MX - Messico 98
EC - Ecuador 93
PL - Polonia 93
MA - Marocco 91
IQ - Iraq 78
NL - Olanda 69
ZA - Sudafrica 69
ID - Indonesia 68
JP - Giappone 57
VE - Venezuela 54
CO - Colombia 52
PK - Pakistan 43
ES - Italia 40
BE - Belgio 38
AT - Austria 32
PY - Paraguay 28
CL - Cile 26
TN - Tunisia 26
UZ - Uzbekistan 26
PH - Filippine 24
SA - Arabia Saudita 22
EG - Egitto 19
UY - Uruguay 18
KE - Kenya 17
MY - Malesia 17
LT - Lituania 16
RS - Serbia 16
NP - Nepal 15
EU - Europa 14
JO - Giordania 14
BO - Bolivia 13
AL - Albania 12
LB - Libano 12
OM - Oman 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
PE - Perù 11
ET - Etiopia 10
DO - Repubblica Dominicana 9
JM - Giamaica 9
KZ - Kazakistan 9
TH - Thailandia 9
TW - Taiwan 9
IL - Israele 8
AU - Australia 7
AZ - Azerbaigian 7
CR - Costa Rica 7
IR - Iran 7
PS - Palestinian Territory 7
CH - Svizzera 6
HR - Croazia 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
HN - Honduras 5
MD - Moldavia 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
CG - Congo 4
GE - Georgia 4
GR - Grecia 4
PA - Panama 4
SV - El Salvador 4
BY - Bielorussia 3
EE - Estonia 3
GA - Gabon 3
GT - Guatemala 3
KW - Kuwait 3
NI - Nicaragua 3
PR - Porto Rico 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
Totale 35.408
Salva come PNG Salva come JPEG
Città #
Ashburn 2.202
Chandler 1.448
Jacksonville 1.410
Singapore 1.324
Fairfield 836
Dublin 743
Boardman 683
Dallas 670
San Jose 601
Ho Chi Minh City 557
Wilmington 546
Hong Kong 494
New York 452
Woodbridge 393
Houston 372
Hanoi 360
Seattle 346
Beijing 338
Council Bluffs 331
Centro 323
The Dalles 313
Des Moines 311
Lawrence 295
Princeton 295
San Mateo 295
Lauterbourg 270
Munich 257
Los Angeles 250
Moscow 237
Cambridge 231
Ann Arbor 224
Hefei 160
Helsinki 150
São Paulo 142
Milan 136
Abidjan 129
San Diego 110
Buffalo 95
Da Nang 86
Orem 80
Chicago 79
Haiphong 73
London 70
Turin 69
Warsaw 64
Santa Clara 55
Ancona 54
Rio de Janeiro 51
Turku 48
Pune 46
Montreal 44
Chennai 43
Frankfurt am Main 42
Guangzhou 42
Tokyo 42
Johannesburg 40
Denver 39
Miano 39
Washington 39
Brooklyn 37
Nuremberg 37
Stockholm 37
Rome 36
Shanghai 36
Boston 35
Brussels 35
Marche 35
Redmond 35
Belo Horizonte 34
Atlanta 33
Porto Alegre 32
Quito 31
Brasília 30
Mexico City 29
Baghdad 28
Curitiba 28
Norwalk 28
Guayaquil 27
Phoenix 27
Hải Dương 26
Poplar 26
Manchester 24
Biên Hòa 23
Tashkent 23
Wuhan 23
Amsterdam 22
Jesi 22
Toronto 22
Porto 20
San Francisco 20
Ankara 19
Charlotte 19
Jiaxing 19
Thái Bình 19
Auburn Hills 18
Montevideo 18
Guarulhos 17
Izmir 17
Salt Lake City 17
Belgrade 16
Totale 20.554
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 842
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 810
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 304
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 210
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 191
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 190
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 184
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 180
Metabolomic profile of systemic sclerosis patients 177
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 174
Adalimumab modulates angiogenesis in psoriatic skin 174
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 174
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 173
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 171
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 170
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 169
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 169
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 166
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 166
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 165
c-MYB transactivates the alpha 2(I) collagen gene. 164
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 160
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 160
Abnormal cerebrovascular reactivity and cognitive impairment in systemic sclerosis 159
Cardiac involvement in polymyositis and dermatomyositis 158
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 156
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 155
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 153
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 153
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 153
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 152
La terapia con immunoglobuline endovena nelle malattie autoimmuni 151
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 151
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 151
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 151
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 151
Cognitive and cerebral hemodynamic impairment in scleroderma patients 149
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 149
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 149
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 149
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 149
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 148
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 147
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 147
Diagnosis and management of leukocytoclastic vasculitis 147
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 146
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 146
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 146
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 145
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 144
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 142
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 142
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 142
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry 142
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 141
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 141
Subcutaneous IgG in the Myositis Spectrum Disorders 141
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 140
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 139
Certolizumab pegol for the treatment of psoriasis 139
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 138
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 137
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 137
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 137
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 137
Mapping and predicting mortality from systemic sclerosis 137
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 136
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 135
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 135
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 135
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 134
A painful diagnosis 134
Biologics in inflammatory immune-mediated systemic diseases 133
Digital ulcers predict a worse disease course in patients with systemic sclerosis 133
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 133
Assessment of gastrointestinal involvement in scleroderma. 132
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 132
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 132
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 132
Agonistic antibodies in systemic sclerosis 132
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 130
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 130
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 130
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 130
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 129
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 129
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 129
Traiano: Educational (but not only) opportunity for Master Students 129
A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA). 129
Subclinical progression of systemic sclerosis-related cardiomyopathy 128
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 128
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 127
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 127
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 126
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 126
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 125
Pathogenic autoantibodies in systemic sclerosis 125
Dr. Guerra, et al reply 125
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 125
History and scientific production of clinica medica and clinica ematologica in ancona 125
Totale 16.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.100 109 537 62 131 17 106 77 159 126 129 201 446
2022/20234.169 380 433 343 353 306 688 13 279 1.009 38 218 109
2023/20242.235 419 47 135 345 350 487 37 56 13 68 21 257
2024/20254.554 425 425 197 43 205 118 481 163 1.051 329 477 640
2025/202613.841 914 1.088 721 1.498 1.299 887 2.039 1.285 2.257 897 334 622
2026/2027303 303 0 0 0 0 0 0 0 0 0 0 0
Totale 35.867